TP53
Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?
Hemasphere
.
2023 Apr 4;7(4):e855.
doi: 10.1097/HS9.0000000000000855.
eCollection 2023 Apr.
Authors
Riccardo Bomben
1
,
Antonella Zucchetto
1
,
Federico Pozzo
1
,
Erika Tissino
1
,
Tamara Bittolo
1
,
Jacopo Olivieri
2
,
Annalisa Chiarenza
3
,
Francesco Zaja
4
,
Maria Ilaria Del Principe
5
,
Davide Rossi
6
7
,
Valter Gattei
1
Affiliations
1
Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy.
2
Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy.
3
Division of Haematology, Ferrarotto Hospital, Catania, Italy.
4
Department of Medical, Surgical and Health Sciences, University of Trieste, Italy.
5
Division of Haematology, University of Tor Vergata, Rome, Italy.
6
Haematology, Institute of Oncology Research, Bellinzona, Switzerland.
7
Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
PMID:
37034005
PMCID:
PMC10079334
DOI:
10.1097/HS9.0000000000000855
No abstract available
Publication types
Editorial